The Electrocochleograph market is dominated by North America, which holds a 40% share in the regional forecast, driven by robust healthcare infrastructure, high adoption of advanced diagnostic tools, and strong R&D investments. Europe follows with a 25% share, fueled by stringent regulatory frameworks ensuring device quality, aging demographics boosting demand, and cross-border collaborations in audiological research. The Asia Pacific region emerges as the fastest-growing market, projected to expand at a CAGR of 8.5%, supported by rising healthcare investments, improving diagnostic accessibility, and a surge in otological disorders. Latin America (10% share) and the Middle East & Africa (5% share) register moderate growth, underpinned by public-private partnerships and infrastructure upgrades, though constrained by economic disparities.